{
  "created_at": "Mon Dec 13 10:38:17 +0000 2021",
  "id_str": "1470328917982646275",
  "full_text": "People who had received a third shot of the Pfizer-BioNTech Covid-19 vaccine showed a level of neutralization against the Omicron variant about 100 times higher than those who had received two shots, a new Israeli study found https://t.co/ezk3hMNCX8",
  "display_text_range": [
    0,
    249
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/ezk3hMNCX8",
        "expanded_url": "https://on.wsj.com/3yoK00u",
        "display_url": "on.wsj.com/3yoK00u",
        "indices": [
          226,
          249
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 45,
  "favorite_count": 92,
  "possibly_sensitive": false,
  "original_created_at": "Mon Dec 13 09:45:06 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "ファイザー社とバイオンテック社が共同開発したCovid-19ワクチンの3回目の接種を受けた人は、2回目の接種を受けた人に比べて、Omicron変異体に対する中和レベルが約100倍高いことが、イスラエルの新しい研究で明らかになった。https://t.co/ezk3hMNCX8"
    },
    {
      "locale": "zh",
      "full_text": "以色列的一项新研究发现，接受过辉瑞-生物技术公司Covid-19疫苗第三针的人对Omicron变体的中和水平比接受过两针的人高约100倍，https://t.co/ezk3hMNCX8。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "以色列的一項新研究發現，接受過輝瑞-生物技術公司Covid-19疫苗第三針的人對Omicron變體的中和水平比接受過兩針的人高約100倍，https://t.co/ezk3hMNCX8。"
    }
  ]
}